ASMB Assembly Biosciences Inc

Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.

$4.48
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
12/17/2010
38,246,092
2,031,789
$171,342,492
0.00%
SEC Edgar Online
10-Q
10-K
045396108
US0453961080
BP4WW00

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-2.76
0.63
2.17
-25.83%
-78.57%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy